# CGM for Insulin-Treated T2DM During Post-Discharge Transition

Study · id `cardio:ct-nct07414277` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07414277](<https://clinicaltrials.gov/study/NCT07414277>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07414277

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT07414277. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT07414277, source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)
- Started: 2026-05-11 (actual) (ClinicalTrials.gov record NCT07414277, source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)
- Primary completion: 2027-09-30 (anticipated) (ClinicalTrials.gov record NCT07414277, source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07414277, source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07414277, source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07414277-2026-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: CGM for Insulin-Treated T2DM During Post-Discharge Transition
- Acronym: TRANSIT-CGM
- Condition: Type 2 Diabetes Mellitus (T2DM)
- Intervention (Device): RT-CGM
- Intervention (Device): SMBG
- Lead sponsor: Shanghai 6th People's Hospital
- Lead sponsor class: OTHER
- Collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Collaborator class: OTHER
- Collaborator: Shanghai Fengxian District Central Hospital
- Collaborator class: OTHER
- Collaborator: Shanghai 7th People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Shanghai 6th People's Hospital (`cardio:org-shanghai-6th-people-s-hospital`)
- Registry lists this organization as a collaborator: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (`cardio:org-shanghai-general-hospital-shanghai-jiao-tong-university-237209`)
- Registry lists this organization as a collaborator: Shanghai 7th People's Hospital (`cardio:org-shanghai-7th-people-s-hospital`)

## Provenance

Content hash: 62ba114520d62cbde284171b1f57ccfba44c387c442810ffd017399eb3fd592b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
